A New Standard for Submitting Protein and Nucleic Acid Sequences – “ST.26”
Up until now, there has been an international system for disclosing nucleic acid and proteins sequences in a format that can be used by patent offices for searching and examination of patent applications. This system is administered by the World Intellectual Property...
Updated Guidelines for Chinese Patent Examination
Key Revisions to the Chinese Guidelines for Patent Examination Supplementary Data Historically, in China, the rules on submitting supplementary data in favour of sufficiency and/or inventive step have been very strict throughout patent prosecution. This was bad news...
T844/18 Confirms Legal Certainty in the EPO’s Consistent Interpretation of the Priority Provisions in Art. 87(1) EPC
Warning: foreach() argument must be of type array|object, bool given in /home/schlich/www/www/wp-content/themes/Schlich/functions.php on line 449
Overview of decision On 6 November 2020, the EPO Technical Board of Appeal (TBA) formally (and finally) handed down its written decision in T844/18 relating to priority and confirmed revocation of the Broad Institute Inc.’s CRISPR/Cas9 patent EP2771468[3]. This...
Recent Comments